« back

Sight Research UK: Translational Research Award

  Tuesday, 30 Nov 2021 | Funding Deadline

Sight Research UK funds pioneering research into the causes of eye disease, in order to develop better prevention methods and more effective treatments for children and adults.

The Translational Research Award supports research projects with a clearly defined pathway to achieving patient benefit. Its goal is to help to accelerate the translation of scientific findings to the early stages of development of new therapies, devices, and diagnostics. Sight Research UK welcomes projects that have robust commercial potential, likely to attract large scale follow-on funding from other charitable, statutory or industry funders.

Eligible projects must:

• Be based on unmet clinical need.
• Aim to generate lead candidates for therapeutic applications.
• Be relevant to and highly promising in the clinical setting (these are not early stage, proof of concept studies, instead they have already shown that the idea might be used as therapy in man).
• Be focused on assessing properties such as potency, efficacy, selectivity, or bioavailability of compounds identified by previous research as potentially strong candidates for therapeutic applications.
• Have a clear pathway to apply for funding such as the MRC Confidence in Concept, MRC Development Pathway Funding Scheme type funding and other similar funding schemes.
•  

Deadline for proposals: 30 November 2021

Find out more here